Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

Abstract

In liver transplant patients, chronic immunosuppression increases the risk of acquiring COVID-19 but it could reduce disease severity. Com- plete immunosuppression with- drawal may not be justified. However, mycophenolate withdrawal or tem- porary conversion to calcineurin inhibitors or everolimus until disease resolution could be beneficial in hos- pitalised patients